<DOC>
	<DOCNO>NCT01908764</DOCNO>
	<brief_summary>The purpose study describe pharmacokinetics AL-60371 otic suspension follow two posology bilateral ototopical dos pediatric subject immediately bilateral tympanostomy tube surgery .</brief_summary>
	<brief_title>Pharmacokinetic Study AL-60371 Otic Suspension Pediatric Subjects Following Tympanostomy Tube Surgery</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<criteria>Requires bilateral myringotomy tympanostomy tube insertion ; Provides inform consent ( parent/legal guardian ) ; Signs assent form applicable ( subject ) ; Accompanied parent/legal guardian visit ; Other protocoldefined inclusion criterion may apply . Menarcheal females ; Current recent history disease , opinion Principal Investigator , may place subject risk interfere study ; Use exclude medication within one week prior surgery duration study ; Requires another surgical procedure addition myringotomy ; Clinically relevant otic condition , opinion Principal Investigator , would preclude safe administration study medication ; Participation investigational study within 30 day entry study along study ; Known suspect allergy hypersensitivity active inactive ingredient test article ; Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>ear tube</keyword>
	<keyword>tympanostomy tube</keyword>
	<keyword>Otitis Media time Tympanostomy Tube surgery</keyword>
	<keyword>OMTT</keyword>
</DOC>